Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,103 | -3,145 | -4,301 | -2,115 | -2,592 |
| Depreciation Amortization | 391 | 553 | 374 | 216 | 8 |
| Other Working Capital | 1,369 | 1,654 | 2,540 | 1,437 | 1,848 |
| Other Operating Activity | 199 | -18 | 874 | -25 | 308 |
| Operating Cash Flow | $-144 | $-956 | $-513 | $-488 | $-427 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -95 | 11 | 275 | 478 | 80 |
| Debt Issued | 238 | 829 | 60 | 23 | 100 |
| Common Stock Issued | N/A | 117 | 163 | N/A | 196 |
| Other Financing Activity | 0 | 0 | 0 | -30 | 0 |
| Financing Cash Flow | $143 | $957 | $497 | $471 | $376 |
| Beginning Cash Position | 1 | 1 | 17 | 33 | 85 |
| End Cash Position | 0 | 1 | 1 | 17 | 33 |
| Net Cash Flow | $-1 | $1 | $-16 | $-17 | $-52 |
| Free Cash Flow | |||||
| Operating Cash Flow | -144 | -956 | -513 | -488 | -427 |
| Free Cash Flow | -144 | -956 | -513 | -488 | -427 |